The inability to control the internal surgical wound environment has been a long-standing Achilles heel of surgery. The development of this technology platform has promising potential to achieve the goal of controlling deep surgical spaces.
IC Surgical began with a vision to transform surgery by addressing surgical tissue damage and the resulting complications, such as seroma. Dr. Brad Bengtson, a renowned plastic surgeon, recognized that this long-standing issue in surgery had no real solution. Complications associated with poor internal tissue healing have been viewed as an inevitable consequence of surgery.
IC Surgical set out to provide internal wound control by delivering internal suction pressure. Through a series of inventions and experiments, the goal was realized through a specially designed implantable Manifold paired with a portable Therapy Unit.
The inability to control the internal surgical wound environment has been a long-standing Achilles heel of surgery. The development of this technology platform has promising potential to achieve the goal of controlling deep surgical spaces.
By delivering internal suction pressure broadly to surgically-damaged tissues, the IC Surgical technology platform has the potential to provide internal wound control that until now has not been possible.
Click on any below to learn more.